Schedule 13D ownership disclosure
LEAP THERAPEUTICS INC
Security class unavailable · CUSIP: 52187K101
Event date: 2021-09-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,153,074
- Percent of class
- 13.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001651308-21-000200
- Form type
- SC 13D
- Filer
- BeOne Medicines Ltd.
- CIK
- CIK 1651308
- Filed
- Sep 29, 2021
- Reporting period
- Sep 24, 2021
- Description
- Schedule 13D beneficial ownership